The effect of fluconazole treatment on tumor necrosis factor-alpha production in murine candidiasis

Yale J Biol Med. 2002 Sep-Dec;75(5-6):241-5.

Abstract

That systemic candidiasis increases TNF-alpha has been proved in various studies. In our study, we investigated if fluconazole too, which is used in treatment, has an additional effect on the increase of TNF-alpha. On the sixth day of the experimental infection, it was measured that TNF-alpha levels of candidiasis was 699 +/- 60 pg/ml whereas it was 683 +/- 35 pg/ml in the mice that were treated with fluconazole. TNF-alpha levels were measured by enzyme-linked immunosorbant assay. Due to the fact that no statistically significant difference was found between them (p > .05) it was thought that fluconazole did not have an additional effect on the increase of TNF-alpha in candidiasis.

MeSH terms

  • Animals
  • Antifungal Agents / metabolism
  • Antifungal Agents / therapeutic use*
  • Candidiasis / blood
  • Candidiasis / drug therapy*
  • Female
  • Fluconazole / metabolism
  • Fluconazole / therapeutic use*
  • Kidney / microbiology
  • Mice
  • Mice, Inbred BALB C
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Antifungal Agents
  • Tumor Necrosis Factor-alpha
  • Fluconazole